Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Clinical Trial Results
Pharma
Eli Lilly eyes tirzepatide cardio filings after late-stage win
Lilly's tirzepatide, already approved in diabetes and obesity, has scored in another disease.
Eric Sagonowsky
Aug 1, 2024 10:01am
Gilead trumpets a Biktarvy win in HIV, hepatitis B co-infection
Aug 1, 2022 10:17am
The FDA says Ocugen needs to hand over results from a 2019 study
Apr 26, 2022 8:40am
AZ, Daiichi's Enhertu touts HER2-low breast cancer win
Feb 22, 2022 8:55am
Opiant's nasal opioid overdose drug clears PK test
Feb 14, 2022 6:45am
Safety analysis of Biogen’s Alzheimer's med details ARIA concern
Nov 23, 2021 9:45am
